Candel Therapeutics Competitors and Similar CompaniesClear all
Candel Therapeutics's competitors and similar companies include Signpath Pharma, Trethera and Allogene Therapeutics.
 Candel Therapeutics Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies. |  Signpath Pharma SignPath Pharma is a biotechnology company that develops products to treat cancer and mitigate drug-induced cardiac arrhythmia. |  Allogene Therapeutics Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer. | ||
Founding Date | Founding Date 1999 | Founding Date 2006 | Founding Date 2013 | Founding Date 2018 |
Type | Type Public | Type Private | Type Private | Type Public |
Tags | ||||
Locations | Locations Needham, US HQ | Locations Sandy, US HQ | Locations Los Angeles, US HQ | Locations South San Francisco, US HQ |
Employees | Employees 50 | Employees 10 | Employees 6 | Employees 35917% increase |
Valuation ($) | Valuation ($) 222.3 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 558.3 m |
Financial | ||||
Net income | Net income ($37.9m) (FY, 2023) | Net income N/A | Net income N/A | Net income ($332.6m) (FY, 2022) |
Funding | ||||
Total funding raised | Total funding raised $ 64.6m | Total funding raised $ 5.3m | Total funding raised $ 7.4m | Total funding raised $ 532m |
For sources of this data, please see the company profile
View Company Profiles
Signpath Pharma
HQ
Sandy, US
Employees
10
SignPath Pharma is a biotechnology company that develops products to treat cancer and mitigate drug-induced cardiac arrhythmia.
View company
Trethera
HQ
Los Angeles, US
Employees
6
Trethera is a preclinical-stage biopharmaceutical company developing cancer treatments.
View companyAllogene Therapeutics
HQ
South San Francisco, US
Employees
359↑ 17% increase
Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer.
View company